IBDEI02C ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2597,1,1,0)
 ;;=1^173.12
 ;;^UTILITY(U,$J,358.3,2597,1,8,0)
 ;;=8^SCC Skin of Eyelid/Canthus
 ;;^UTILITY(U,$J,358.3,2597,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,2598,0)
 ;;=173.21^^29^213^2
 ;;^UTILITY(U,$J,358.3,2598,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2598,1,1,0)
 ;;=1^173.21
 ;;^UTILITY(U,$J,358.3,2598,1,8,0)
 ;;=8^BCC Skin of Ear/Ext Canal
 ;;^UTILITY(U,$J,358.3,2598,2)
 ;;=^340470
 ;;^UTILITY(U,$J,358.3,2599,0)
 ;;=173.22^^29^213^14
 ;;^UTILITY(U,$J,358.3,2599,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2599,1,1,0)
 ;;=1^173.22
 ;;^UTILITY(U,$J,358.3,2599,1,8,0)
 ;;=8^SCC Skin of Ear/Ext Canal
 ;;^UTILITY(U,$J,358.3,2599,2)
 ;;=^340471
 ;;^UTILITY(U,$J,358.3,2600,0)
 ;;=173.31^^29^213^4
 ;;^UTILITY(U,$J,358.3,2600,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2600,1,1,0)
 ;;=1^173.31
 ;;^UTILITY(U,$J,358.3,2600,1,8,0)
 ;;=8^BCC Skin of Face
 ;;^UTILITY(U,$J,358.3,2600,2)
 ;;=^340473
 ;;^UTILITY(U,$J,358.3,2601,0)
 ;;=173.32^^29^213^16
 ;;^UTILITY(U,$J,358.3,2601,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2601,1,1,0)
 ;;=1^173.32
 ;;^UTILITY(U,$J,358.3,2601,1,8,0)
 ;;=8^SCC Skin of Face
 ;;^UTILITY(U,$J,358.3,2601,2)
 ;;=^340474
 ;;^UTILITY(U,$J,358.3,2602,0)
 ;;=173.41^^29^213^6
 ;;^UTILITY(U,$J,358.3,2602,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2602,1,1,0)
 ;;=1^173.41
 ;;^UTILITY(U,$J,358.3,2602,1,8,0)
 ;;=8^BCC Skin of Scalp/Neck
 ;;^UTILITY(U,$J,358.3,2602,2)
 ;;=^340476
 ;;^UTILITY(U,$J,358.3,2603,0)
 ;;=173.42^^29^213^18
 ;;^UTILITY(U,$J,358.3,2603,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2603,1,1,0)
 ;;=1^173.42
 ;;^UTILITY(U,$J,358.3,2603,1,8,0)
 ;;=8^SCC Skin of Scalp/Neck
 ;;^UTILITY(U,$J,358.3,2603,2)
 ;;=^340477
 ;;^UTILITY(U,$J,358.3,2604,0)
 ;;=173.51^^29^213^7
 ;;^UTILITY(U,$J,358.3,2604,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2604,1,1,0)
 ;;=1^173.51
 ;;^UTILITY(U,$J,358.3,2604,1,8,0)
 ;;=8^BCC Skin of Trunk
 ;;^UTILITY(U,$J,358.3,2604,2)
 ;;=^340479
 ;;^UTILITY(U,$J,358.3,2605,0)
 ;;=173.52^^29^213^19
 ;;^UTILITY(U,$J,358.3,2605,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2605,1,1,0)
 ;;=1^173.52
 ;;^UTILITY(U,$J,358.3,2605,1,8,0)
 ;;=8^SCC Skin of Trunk
 ;;^UTILITY(U,$J,358.3,2605,2)
 ;;=^340480
 ;;^UTILITY(U,$J,358.3,2606,0)
 ;;=198.7^^29^214^1
 ;;^UTILITY(U,$J,358.3,2606,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2606,1,1,0)
 ;;=1^198.7
 ;;^UTILITY(U,$J,358.3,2606,1,8,0)
 ;;=8^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,2606,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,2607,0)
 ;;=198.5^^29^214^2
 ;;^UTILITY(U,$J,358.3,2607,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2607,1,1,0)
 ;;=1^198.5
 ;;^UTILITY(U,$J,358.3,2607,1,8,0)
 ;;=8^Bone/Bone Marrow Mestastasis
 ;;^UTILITY(U,$J,358.3,2607,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,2608,0)
 ;;=198.3^^29^214^3
 ;;^UTILITY(U,$J,358.3,2608,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2608,1,1,0)
 ;;=1^198.3
 ;;^UTILITY(U,$J,358.3,2608,1,8,0)
 ;;=8^Brain Metastasis
 ;;^UTILITY(U,$J,358.3,2608,2)
 ;;=^267334
 ;;^UTILITY(U,$J,358.3,2609,0)
 ;;=198.4^^29^214^4
 ;;^UTILITY(U,$J,358.3,2609,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2609,1,1,0)
 ;;=1^198.4
 ;;^UTILITY(U,$J,358.3,2609,1,8,0)
 ;;=8^Leptomeningeal Metastasis
 ;;^UTILITY(U,$J,358.3,2609,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,2610,0)
 ;;=197.7^^29^214^5
 ;;^UTILITY(U,$J,358.3,2610,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2610,1,1,0)
 ;;=1^197.7
 ;;^UTILITY(U,$J,358.3,2610,1,8,0)
 ;;=8^Liver Metastasis
 ;;^UTILITY(U,$J,358.3,2610,2)
 ;;=^267328
 ;;^UTILITY(U,$J,358.3,2611,0)
 ;;=197.0^^29^214^6
 ;;^UTILITY(U,$J,358.3,2611,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2611,1,1,0)
 ;;=1^197.0
 ;;^UTILITY(U,$J,358.3,2611,1,8,0)
 ;;=8^Lung Metastasis
 ;;^UTILITY(U,$J,358.3,2611,2)
 ;;=^267322
 ;;^UTILITY(U,$J,358.3,2612,0)
 ;;=196.2^^29^214^7
 ;;^UTILITY(U,$J,358.3,2612,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2612,1,1,0)
 ;;=1^196.2
 ;;^UTILITY(U,$J,358.3,2612,1,8,0)
 ;;=8^Lymph Nodes, Abdominal
 ;;^UTILITY(U,$J,358.3,2612,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,2613,0)
 ;;=196.3^^29^214^8
 ;;^UTILITY(U,$J,358.3,2613,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2613,1,1,0)
 ;;=1^196.3
 ;;^UTILITY(U,$J,358.3,2613,1,8,0)
 ;;=8^Lymph Nodes,Axillary & Upper Limb
 ;;^UTILITY(U,$J,358.3,2613,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,2614,0)
 ;;=196.0^^29^214^9
 ;;^UTILITY(U,$J,358.3,2614,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2614,1,1,0)
 ;;=1^196.0
 ;;^UTILITY(U,$J,358.3,2614,1,8,0)
 ;;=8^Lymph Nodes,Cervical,Hd,Face,Neck
 ;;^UTILITY(U,$J,358.3,2614,2)
 ;;=^267314
 ;;^UTILITY(U,$J,358.3,2615,0)
 ;;=196.1^^29^214^10
 ;;^UTILITY(U,$J,358.3,2615,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2615,1,1,0)
 ;;=1^196.1
 ;;^UTILITY(U,$J,358.3,2615,1,8,0)
 ;;=8^Lymph Nodes,Intrathoracic
 ;;^UTILITY(U,$J,358.3,2615,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,2616,0)
 ;;=196.8^^29^214^11
 ;;^UTILITY(U,$J,358.3,2616,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2616,1,1,0)
 ;;=1^196.8
 ;;^UTILITY(U,$J,358.3,2616,1,8,0)
 ;;=8^Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,2616,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,2617,0)
 ;;=198.2^^29^214^12
 ;;^UTILITY(U,$J,358.3,2617,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2617,1,1,0)
 ;;=1^198.2
 ;;^UTILITY(U,$J,358.3,2617,1,8,0)
 ;;=8^Secondary Malig Neo Skin
 ;;^UTILITY(U,$J,358.3,2617,2)
 ;;=^267333
 ;;^UTILITY(U,$J,358.3,2618,0)
 ;;=V65.3^^29^215^4
 ;;^UTILITY(U,$J,358.3,2618,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2618,1,1,0)
 ;;=1^V65.3
 ;;^UTILITY(U,$J,358.3,2618,1,8,0)
 ;;=8^Dietary Surveil/Counseling
 ;;^UTILITY(U,$J,358.3,2618,2)
 ;;=^295563
 ;;^UTILITY(U,$J,358.3,2619,0)
 ;;=V79.1^^29^215^1
 ;;^UTILITY(U,$J,358.3,2619,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2619,1,1,0)
 ;;=1^V79.1
 ;;^UTILITY(U,$J,358.3,2619,1,8,0)
 ;;=8^Alcoholism Screening
 ;;^UTILITY(U,$J,358.3,2619,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,2620,0)
 ;;=V79.0^^29^215^3
 ;;^UTILITY(U,$J,358.3,2620,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2620,1,1,0)
 ;;=1^V79.0
 ;;^UTILITY(U,$J,358.3,2620,1,8,0)
 ;;=8^Depression Screening
 ;;^UTILITY(U,$J,358.3,2620,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,2621,0)
 ;;=V65.49^^29^215^7
 ;;^UTILITY(U,$J,358.3,2621,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2621,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,2621,1,8,0)
 ;;=8^Medication Counseling
 ;;^UTILITY(U,$J,358.3,2621,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,2622,0)
 ;;=V66.2^^29^215^2
 ;;^UTILITY(U,$J,358.3,2622,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2622,1,1,0)
 ;;=1^V66.2
 ;;^UTILITY(U,$J,358.3,2622,1,8,0)
 ;;=8^Chemotherapy Convalescen
 ;;^UTILITY(U,$J,358.3,2622,2)
 ;;=^295568
 ;;^UTILITY(U,$J,358.3,2623,0)
 ;;=V76.10^^29^215^10
 ;;^UTILITY(U,$J,358.3,2623,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2623,1,1,0)
 ;;=1^V76.10
 ;;^UTILITY(U,$J,358.3,2623,1,8,0)
 ;;=8^Screen Mal Neopl, Breast,Unsp
 ;;^UTILITY(U,$J,358.3,2623,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,2624,0)
 ;;=V76.2^^29^215^8
 ;;^UTILITY(U,$J,358.3,2624,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2624,1,1,0)
 ;;=1^V76.2
 ;;^UTILITY(U,$J,358.3,2624,1,8,0)
 ;;=8^Screen Mal Neop-Cervix
 ;;^UTILITY(U,$J,358.3,2624,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,2625,0)
 ;;=V76.41^^29^215^9
 ;;^UTILITY(U,$J,358.3,2625,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2625,1,1,0)
 ;;=1^V76.41
 ;;^UTILITY(U,$J,358.3,2625,1,8,0)
 ;;=8^Screen Mal Neop-Rectum
 ;;^UTILITY(U,$J,358.3,2625,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,2626,0)
 ;;=V26.33^^29^215^6
 ;;^UTILITY(U,$J,358.3,2626,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2626,1,1,0)
 ;;=1^V26.33
 ;;^UTILITY(U,$J,358.3,2626,1,8,0)
 ;;=8^Genetic Counseling
 ;;^UTILITY(U,$J,358.3,2626,2)
 ;;=^332865
 ;;^UTILITY(U,$J,358.3,2627,0)
 ;;=V58.11^^29^215^5
 ;;^UTILITY(U,$J,358.3,2627,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2627,1,1,0)
 ;;=1^V58.11
 ;;^UTILITY(U,$J,358.3,2627,1,8,0)
 ;;=8^Encounter for Chemotherapy
 ;;^UTILITY(U,$J,358.3,2627,2)
 ;;=^332869
 ;;^UTILITY(U,$J,358.3,2628,0)
 ;;=282.60^^29^216^8
 ;;^UTILITY(U,$J,358.3,2628,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2628,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,2628,1,8,0)
 ;;=8^Sickle-Cell Anemia Nos
 ;;^UTILITY(U,$J,358.3,2628,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,2629,0)
 ;;=282.62^^29^216^5
 ;;^UTILITY(U,$J,358.3,2629,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2629,1,1,0)
 ;;=1^282.62
 ;;^UTILITY(U,$J,358.3,2629,1,8,0)
 ;;=8^Hb-S Disease With Crisis
 ;;^UTILITY(U,$J,358.3,2629,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,2630,0)
 ;;=282.61^^29^216^4
 ;;^UTILITY(U,$J,358.3,2630,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2630,1,1,0)
 ;;=1^282.61
 ;;^UTILITY(U,$J,358.3,2630,1,8,0)
 ;;=8^Hb-S Disease W/O Crisis
 ;;^UTILITY(U,$J,358.3,2630,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,2631,0)
 ;;=282.69^^29^216^6
 ;;^UTILITY(U,$J,358.3,2631,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2631,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,2631,1,8,0)
 ;;=8^Other Sickle Cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,2631,2)
 ;;=^87863
 ;;^UTILITY(U,$J,358.3,2632,0)
 ;;=282.5^^29^216^9
 ;;^UTILITY(U,$J,358.3,2632,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2632,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,2632,1,8,0)
 ;;=8^Sickle-Cell Trait
 ;;^UTILITY(U,$J,358.3,2632,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,2633,0)
 ;;=282.63^^29^216^10
 ;;^UTILITY(U,$J,358.3,2633,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2633,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,2633,1,8,0)
 ;;=8^Sickle-Cell/Hb-C Disease
 ;;^UTILITY(U,$J,358.3,2633,2)
 ;;=^267983
 ;;^UTILITY(U,$J,358.3,2634,0)
 ;;=282.41^^29^216^13
 ;;^UTILITY(U,$J,358.3,2634,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2634,1,1,0)
 ;;=1^282.41
 ;;^UTILITY(U,$J,358.3,2634,1,8,0)
 ;;=8^Thalassemias
 ;;^UTILITY(U,$J,358.3,2634,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,2635,0)
 ;;=282.49^^29^216^12
 ;;^UTILITY(U,$J,358.3,2635,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2635,1,1,0)
 ;;=1^282.49
